Evidence map›Paper›PMID 30234457›Full record

ArticleRadiation research2018

Dicentric Dose Estimates for Patients Undergoing Radiotherapy in the RTGene Study to Assess Blood Dosimetric Models and the New Bayesian Method for Gradient Exposure.

Jayne Moquet, Manuel Higueras, Ellen Donovan, Sue Boyle, Stephen Barnard, Clare Bricknell, Mingzhu Sun, Lone Gothard, Grainne O'Brien, Lourdes Cruz-Garcia and 3 more

Abstract read
In one paragraph

Article in Radiation research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jayne MoquetPublic Health England, Centre for Radiation, Chemical and Environmental Hazards (PHE-CRCE), Chilton, Didcot, Oxford OX11 0RQ, United Kingdom.
Manuel HiguerasBasque Center for Applied Mathematics, 48009 Bilbao, Spain.
Ellen DonovanCentre for Vision Speech and Signal Processing, University of Surrey, Guildford, GU2 7XH, United Kingdom.
Sue BoyleInstitute of Cancer Research (ICR), Sutton, London SM2 5NG, United Kingdom.
Stephen BarnardPublic Health England, Centre for Radiation, Chemical and Environmental Hazards (PHE-CRCE), Chilton, Didcot, Oxford OX11 0RQ, United Kingdom.
Clare BricknellPublic Health England, Centre for Radiation, Chemical and Environmental Hazards (PHE-CRCE), Chilton, Didcot, Oxford OX11 0RQ, United Kingdom.
Mingzhu SunPublic Health England, Centre for Radiation, Chemical and Environmental Hazards (PHE-CRCE), Chilton, Didcot, Oxford OX11 0RQ, United Kingdom.
Lone GothardInstitute of Cancer Research (ICR), Sutton, London SM2 5NG, United Kingdom.
Grainne O'BrienPublic Health England, Centre for Radiation, Chemical and Environmental Hazards (PHE-CRCE), Chilton, Didcot, Oxford OX11 0RQ, United Kingdom.
Lourdes Cruz-GarciaPublic Health England, Centre for Radiation, Chemical and Environmental Hazards (PHE-CRCE), Chilton, Didcot, Oxford OX11 0RQ, United Kingdom.
Christophe BadiePublic Health England, Centre for Radiation, Chemical and Environmental Hazards (PHE-CRCE), Chilton, Didcot, Oxford OX11 0RQ, United Kingdom.
Elizabeth AinsburyPublic Health England, Centre for Radiation, Chemical and Environmental Hazards (PHE-CRCE), Chilton, Didcot, Oxford OX11 0RQ, United Kingdom.
Navita SomaiahInstitute of Cancer Research (ICR), Sutton, London SM2 5NG, United Kingdom.

Funding

Sample Engineering CoreU19AI067773 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI FORNACE, ALBERT J · 2005 to 2024
$105.4M
Cancer Research UK 19727NIAID NIH HHS U19 AI067773
6 · The paper itself

Abstract

The RTGene study was focused on the development and validation of new transcriptional biomarkers for prediction of individual radiotherapy patient responses to ionizing radiation. In parallel, for validation purposes, this study incorporated conventional biomarkers of radiation exposure, including the dicentric assay. Peripheral blood samples were taken with ethical approval and informed consent from a total of 20 patients undergoing external beam radiotherapy for breast, lung, gastrointestinal or genitourinary tumors. For the dicentric assay, two samples were taken from each patient: prior to radiotherapy and before the final fraction. Blood samples were set up using standard methods for the dicentric assay. All the baseline samples had dicentric frequencies consistent with the expected background for the normal population. For blood taken before the final fraction, all the samples displayed distributions of aberrations, which are indicative of partial-body exposures. Whole-body and partial-body cytogenetic doses were calculated with reference to a 250-kVp X-ray calibration curve and then compared to the dose to blood derived using two newly developed blood dosimetric models. Initial comparisons indicated that the relationship between these measures of dose appear very promising, with a correlation of 0.88 (

Indexed as

AdultAgedBayes TheoremBiomarkers, TumorBreast NeoplasmsChromosome AberrationsChromosomesDose-Response Relationship, RadiationFemaleGastrointestinal NeoplasmsHumansLung NeoplasmsMaleMiddle AgedRadiation DosageRadiation, IonizingBiomarkers, Tumor

Identifiers

PMID30234457
PMCPMC6426678

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.